Metronidazole (Flagyl) for STI Treatment
For trichomoniasis, use metronidazole 500 mg twice daily for 7 days as first-line therapy; for bacterial vaginosis, use metronidazole 500 mg twice daily for 7 days; and for pelvic inflammatory disease, add metronidazole 500 mg twice daily for 10-14 days to ceftriaxone plus doxycycline for anaerobic coverage.
Trichomoniasis Treatment
The FDA-approved dosing for trichomoniasis is 375 mg twice daily for 7 consecutive days 1. While the 2002 CDC guidelines recommended a single 2-g dose as the primary regimen 2, more recent evidence supports the 7-day course. Both regimens achieve 90-95% cure rates 2, and the 7-day regimen may minimize reinfection by providing coverage while sexual partners obtain treatment 1.
Key Treatment Points:
- Partner treatment is essential - treat all sexual partners simultaneously, even without testing, as this significantly enhances cure rates 3
- No test-of-cure needed if patients become asymptomatic 2
- Treatment failures: If the 7-day regimen fails, re-treat with metronidazole 500 mg twice daily for 7 days; if this fails again, use 2 g once daily for 3-5 days 2
- Pregnancy: Treat symptomatic pregnant women with oral metronidazole (avoid first trimester) to prevent preterm birth 3
Critical Counseling:
- Abstain from sexual activity until both patient and partner complete therapy and are asymptomatic 2
- Avoid alcohol during treatment and for 24 hours after completion (disulfiram-like reaction)
Bacterial Vaginosis Treatment
Metronidazole 500 mg orally twice daily for 7 days is the standard treatment 3, 4. Alternative regimens include vaginal metronidazole gel or clindamycin, but oral therapy is preferred for systemic coverage 5.
Treatment Considerations:
- Diagnosis requires either Amsel criteria (milky discharge, pH >4.5, positive whiff test, clue cells) or Gram stain 3
- Recurrent BV (multiple documented episodes) requires longer courses of therapy 3
- Pregnant women at high risk for preterm delivery: Consider treatment and follow-up evaluation 1 month post-treatment 2
- HIV-positive patients receive identical treatment 2
Pelvic Inflammatory Disease (PID)
For PID, metronidazole provides essential anaerobic coverage, particularly for bacterial vaginosis-associated organisms and when recent uterine instrumentation has occurred 6.
Outpatient PID Regimen:
- Ceftriaxone 1 g IM/IV once (single dose)
- PLUS Doxycycline 100 mg twice daily for 14 days
- PLUS Metronidazole 500 mg twice daily for 10-14 days 7, 6
The 2021 CDC guidelines emphasize routine inclusion of metronidazole in PID treatment 8. French guidelines specify 10 days for uncomplicated PID and 14 days for complicated cases 7.
When to Add Metronidazole:
- Presence of bacterial vaginosis
- Trichomoniasis coinfection
- Recent uterine instrumentation (IUD insertion, abortion, hysterosalpingography)
- Tubo-ovarian abscess 6
Hospitalization Criteria:
- Pregnancy
- Severe illness or inability to tolerate oral medications
- Outpatient treatment failure
- Tubo-ovarian abscess
- Surgical emergency cannot be excluded 6
Common Pitfalls to Avoid
Topical metronidazole gel is ineffective for trichomoniasis (<50% cure rate) and should never be used 2. Only oral formulations achieve therapeutic levels in the urethra and perivaginal glands.
Empirical treatment without proper diagnosis is frequently inappropriate - one study found 55.2% of empirical prescriptions were ineffective or unnecessary 9. When possible, confirm diagnosis with wet mount, culture, or nucleic acid amplification testing before treating.
Partner treatment cannot be overlooked - failure to treat partners is a primary cause of treatment failure and reinfection, particularly with trichomoniasis 3.
Dosage Adjustments
Severe Hepatic Impairment (Child-Pugh C):
- Trichomoniasis: Reduce frequency to 375 mg once daily for 7 days 1
- Amebiasis: Reduce dose by 50% to 375 mg every 8 hours 1
Hemodialysis:
Consider supplemental dosing after dialysis sessions, as hemodialysis removes significant amounts of metronidazole 1.